TotalMarketCap

Gyre Therapeutics

GYRENasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$446.597 M

$4.01 -9.80%

Close of 6 Nov 2026

As of 6 Nov 2026, Gyre Therapeutics (GYRE) has a market capitalization of $446.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$116.6M

#2439 by revenue

Earnings

$9.88M

#2031 by earnings

Shares outstanding

115,321,017

Latest filing cover page

P/E ratio

45.2

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #196Monopar TherapeuticsMNPR$450.8M
  2. #197Shattuck LabsSTTK$450.1M
  3. #198Gyre TherapeuticsGYRE$446.6M
  4. #199ArvinasARVN$427.0M
  5. #200OculisOCS$419.1M

What if Gyre Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$253,223.14

Per share 63,227× higher

Bitcoin $1.53T

$13,701.46

Per share 3,421× higher

Apple $5.02T

$44,980.62

Per share 11,231× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Gyre Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.